Skip to main content

Table 1 Characteristics of WIHS and UHS subjects analyzed for this study.

From: Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression

 

N in category (% of total)

Characteristic

WIHS (N = 2248)

UHS (N = 4623)

HCV seronegative

1666 (74.1%)

576 (12.5%)

HCV seropositive

582 (25.9%)

4047 (87.5%)

Year of HCV test

  

1987–1992

0 (0.0%)

572 (12.4%)

1993

29 (1.3%)

48 (1.0%)

1994

844 (37.5%)

47 (1.0%)

1995

306 (13.6%)

57 (1.2%)

1996

2 (0.1%)

62 (1.3%)

1997

4 (0.2%)

37 (0.8%)

1998

76 (3.4%)

862 (18.6%)

1999

15 (0.7%)

995 (21.5%)

2000

24 (1.1%)

904 (19.6%)

2001

635 (28.2%)

907 (19.6%)

2002

313 (13.9%)

132 (2.9%)

Age at HCV test

  

< 20

58 (2.6%)

67 (1.4%)

20–29

593 (26.4%)

488 (10.6%)

30–39

1048 (46.6%)

1200 (26.0%)

40–49

486 (21.6%)

1925 (41.6%)

50–59

58 (2.6%)

810 (17.5%)

60+

5 (0.2%)

133 (2.9%)

Female

2248 (100%)

1409 (30.5%)

Male

0 (0%)

3214 (69.5%)

Race/Ethnicity

  

Caucasian

275 (12.2%)

1684 (36.4%)

African American

1277 (56.8%)

2232 (48.3%)

Hispanic

615 (27.4%)

401 (8.7%)

Other

81 (3.6%)

306 (6.6%)

Area

  

San Francisco

340 (15.1%)

4623 (100%)

Bronx

459 (20.4%)

0 (0%)

Brooklyn

429 (19.1%)

0 (0%)

Washington, DC

320 (14.2%)

0 (0%)

Los Angeles

397 (17.7%)

0 (0%)

Chicago

303 (13.5%)

0 (0%)

HIV-infected

1627 (72.4%)

787 (17.0%)

Ever IDU

522 (23.2%)

4623 (100%)

Age of First IDU

  

Before 12

4 (0.8%)

123 (2.7%)

12–15

69 (13.2%)

972 (21.0%)

16–19

163 (31.2%)

1520 (32.9%)

20–29

227 (43.5%)

1416 (30.6%)

30–39

56 (10.7%)

464 (10.0%)

40+

3 (0.6%)

128 (2.8%)

Year of First IDU

  

Before1960

2 (0.4%)

198 (4.3%)

1960–1969

78 (14.9%)

1174 (25.4%)

1970–1979

206 (39.5%)

1473 (31.9%)

1980–1989

173 (33.1%)

1015 (22.0%)

1990–1995

43 (8.2%)

459 (9.9%)

After1995

20 (3.8%)

304 (6.6%)

Daily IDU

341 (65.3%)

2992 (64.7%)